Conference Coverage
The Latest
Clinical Trial Data Needs to Reflect the Demographics of HIV, Say Activists
A recent analysis conducted by the AIDS Treatment Activists Coalition revealed that, among HIV drug trial participants, data specific to race and sex were dramatically underreported.
CROI 2021 Data Bites: HIV Prevention and Epidemiology
From new forms of PrEP to new data on HIV in the U.S., CROI 2021 has plenty of developments to report when it comes to preventing HIV and better understanding the drivers of the modern epidemic.
Real Talk at SYNChronicity 2020: Black Women Are Essential to Eliminating HIV
Open conversations between care providers and Black women are vitally important in order to empower women with information about HIV and how to protect their health.
Researchers Discuss the Lessons of the HIV Vaccine Trial That Terminated Earlier This Year
HVTN 702 may not have proven an effective vaccine, but scientists still learned from the research.
Black Gay Men in the Ballroom Scene Experience a Unique Form of HIV Prevention
Though not as widely studied, there are many ways that men who belong to the gay family networks of the ballroom scene may be getting an HIV intervention.
Do Intimate Relationships Affect Drug Use in Black Gay and Bisexual Men?
Men with a main partner used drugs during sex at similar rates to those with only casual partners. But studying couples could lead to HIV prevention programs that could reduce racial disparity.
The HIV Workforce Is in Trouble. Here Are Three Solutions to Address the Shortage of Providers.
If everyone living with HIV gets into care, do we have enough providers to support them? HIV doctors are proposing policy changes to address the workforce shortage.
The State of Cure Research for HIV and Hepatitis B: Similarities and Differences
Steven Deeks, M.D., talks about the medical community's hopes, inspirations, and unanswered questions regarding research for an HIV cure.
Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa
ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.
IAS 2019: What to Expect in HIV Science
Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.